❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Annual reports ❭

Annual reports

Download reports in PDF format:

2024 Single page format Double page format  
2023 Single page format Double page format  
2022 Single page format Double page format  
2021 Single page format Double page format  
2020 Single page format Double page format Abstract (in Norwegian)
2019 Single page format Double page format Abstract (in Norwegian)
2018 Single page format Double page format Abstract (in Norwegian)
2017 Single page format Double page format  
2016 Single page format Double page format  
2015 Single page format    
2014 Single page format    

 

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More selected publications

Most recent publications

Landsverk HB, Sandquist LE, Bay LTE, Hauge S, van Bijsterveldt L, Lindbergsengen L, Lund-Andersen C, Kanduri C, Lyng H, Fjeldbo CS, Hompland T, Humphrey TC, Syljuåsen RG (2026)
Transcription termination counteracts DNA damage after WEE1 inhibition
Nucleic Acids Res, 54 (3)
DOI 10.1093/nar/gkaf1487, PubMed 41569153

Solli E, Bevilacqua A, Wenes M, Migliorini D, van der Veen L, Skånland SS, Di Conza G, Taskén K (2026)
The PI3Kδ inhibitor roginolisib (IOA-244) preserves T-cell function and activity
Mol Oncol (in press)
DOI 10.1002/1878-0261.70203, PubMed 41568714

Teles-Reis J, Rusten TE (2026)
Tumour-host interactions in Drosophila: mechanisms in the tumour micro- and macroenvironment
Mol Oncol (in press)
DOI 10.1002/1878-0261.70207, PubMed 41546533

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)